Dopamine enhances mtNOS activity: Implications in mitochondrial function

Biochimica et Biophysica Acta - Bioenergetics

Volumn 1767, Issue 9, 2007, Pages 1118-1125

  Czerniczyniec, Analía ^a   Bustamante, Juanita ^a   Lores Arnaiz, Silvia ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Brain mitochondria; Dopamine; Mitochondrial membrane potential; Mitochondrial respiration; Nitric oxide

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); CYTOCHROME C OXIDASE; DOPAMINE; HYDROGEN PEROXIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL TISSUE; ARTICLE; ENZYME ACTIVITY; FEMALE; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL RESPIRATION; MOUSE; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL;

ANIMALS; BRAIN; CARDIOTONIC AGENTS; DOPAMINE; HYDROGEN PEROXIDE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MEMBRANE POTENTIALS; MICE; MITOCHONDRIA; MODELS, BIOLOGICAL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXYGEN; OXYGEN CONSUMPTION; SYNAPTOSOMES;

EID: 34548161578     PISSN: 00052728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbabio.2007.07.005     Document Type: Article

References (37)

1. Lai C.T., and Yu P.H. Dopamine and l-beta-3,4-dihydroxyphenylalanine hydrochloride (l-Dopa)-induced cytotoxicity towards catecholaminergic neuroblastoma SH-SY5Y cells. Effects of oxidative stress and antioxidative factors. Biochem. Pharmacol. 53 (1997) 363-372
2. Berman S.B., and Hastings T.G. Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease. J. Neurochem. 73 (1999) 1127-1137
3. Ben-Shachar D., Zuk R., and Glinka Y. Dopamine neurotoxicity: inhibition of mitochondrial respiration. J. Neurochem. 64 (1995) 718-723
4. Gluck M., Ehrhart J., Jayatilleke E., and Zeevalk G.D. Inhibition of brain mitochondrial respiration by dopamine: involvement of H(2)O(2) and hydroxyl radicals but not glutathione-protein-mixed disulfides. J. Neurochem. 82 (2002) 66-74
5. Ben-Shachar D., Zuk R., Gazawi H., and Ljubuncic P. Dopamine toxicity involves mitochondrial complex I inhibition: implications to dopamine-related neuropsychiatric disorders. Biochem. Pharmacol. 67 (2004) 1965-1974
6. Khan F.H., Sen T., Maiti A.K., Jana S., Chatterjee U., and Chakrabarti S. Inhibition of rat brain mitochondrial electron transport chain activity by dopamine oxidation products during extended in vitro incubation: implications for Parkinson's disease. Biochim. Biophys. Acta 1741 (2005) 65-74
7. Gluck M.R., and Zeevalk G.D. Inhibition of brain mitochondrial respiration by dopamine and its metabolites: implications for Parkinson's disease and catecholamine-associated diseases. J. Neurochem. 91 (2004) 788-795
8. Centonze D., Gubellini P., Pisani A., Bernardi G., and Calabresi P. Dopamine, acetylcholine and nitric oxide systems interact to induce corticostriatal synaptic plasticity. Rev. Neurosci. 14 (2003) 207-216
9. Melis M.R., Succu S., and Argiolas A. Dopamine agonists increase nitric oxide production in the paraventricular nucleus of the hypothalamus: correlation with penile erection and yawning. Eur. J. Neurosci. 8 (1996) 2056-2063
10. Sammut S., Dec A., Mitchell D., Linardakis J., Ortiguela M., and West A.R. Phasic dopaminergic transmission increases NO efflux in the rat dorsal striatum via a neuronal NOS and a dopamine D(1/5) receptor-dependent mechanism. Neuropsychopharmacology 31 (2006) 493-505
11. Giulivi C., Poderoso J.J., and Boveris A. Production of nitric oxide by mitochondria. J. Biol. Chem. 273 (1998) 11038-11043
12. Ghafourifar P., and Richter C. Nitric oxide synthase activity in mitochondria. FEBS Lett. 418 (1997) 291-296
13. Giulivi C. Functional implications of nitric oxide produced by mitochondria in mitochondrial metabolism. Biochem. J. 332 Pt 3 (1998) 673-679
14. Lores-Arnaiz S., D'Amico G., Czerniczyniec A., Bustamante J., and Boveris A. Brain mitochondrial nitric oxide synthase: in vitro and in vivo inhibition by chlorpromazine. Arch. Biochem. Biophys. 430 (2004) 170-177
15. Clark J.B., and Nicklas W.J. The metabolism of rat brain mitochondria. Preparation and characterization. J. Biol. Chem. 245 (1970) 4724-4731
16. Boveris A., Arnaiz S.L., Bustamante J., Alvarez S., Valdez L., Boveris A.D., and Navarro A. Pharmacological regulation of mitochondrial nitric oxide synthase. Methods Enzymol. 359 (2002) 328-339
17. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
18. Tyler D., and Gonze J. The preparation of thyroid and thymus mitochondria. Methods Enzymol. 10 (1967) 101-103
19. Murphy M.E., and Noack E. Nitric oxide assay using hemoglobin method. Methods Enzymol. 233 (1994) 240-250
20. Yonetani T. Cytochrome oxidase: beef heart. Methods Enzymol. 10 (1967) 332-335
21. Boveris A., Costa L.E., Cadenas E., and Poderoso J.J. Regulation of mitochondrial respiration by adenosine diphosphate, oxygen, and nitric oxide. Methods Enzymol. 301 (1999) 188-198
22. Estabrook R. Mitochondrial respiratory control and the polarographic measurement of ADP:O ratios. Methods Enzymol. 10 (1967) 41-47
23. Boveris A. Determination of the production of superoxide radicals and hydrogen peroxide in mitochondria. Methods Enzymol. 105 (1984) 429-435
24. Willmot M., Gibson C., Gray L., Murphy S., and Bath P. Nitric oxide synthase inhibitors in experimental ischemic stroke and their effects on infarct size and cerebral blood flow: a systematic review. Free Radic. Biol. Med. 39 (2005) 412-425
25. Kikuchi K., Nagano T., and Hirobe M. Novel detection method of nitric oxide using horseradish peroxidase. Biol. Pharm. Bull. 19 (1996) 649-651
26. Eisenhofer G., Kopin I.J., and Goldstein D.S. Catecholamine metabolism: a contemporary view with implications for physiology and medicine. Pharmacol. Rev. 56 (2004) 331-349
27. Barzilai A., Melamed E., and Shirvan A. Is there a rationale for neuroprotection against dopamine toxicity in Parkinson's disease?. Cell. Mol. Neurobiol. 21 (2001) 215-235
28. Lores Arnaiz S., D'Amico G., Paglia N., Arismendi M., Basso N., and Lores Arnaiz M.R. Enriched environment, nitric oxide production and synaptic plasticity prevent the aging-dependent impairment of spatial cognition. Mol. Aspects Med. 25 (2004) 91-101
29. Brown G.C. Regulation of mitochondrial respiration by nitric oxide inhibition of cytochrome c oxidase. Biochim. Biophys. Acta 1504 (2001) 46-57
30. Czerniczyniec A., Bustamante J., and Lores-Arnaiz S. Modulation of brain mitochondrial function by deprenyl. Neurochem. Int. 48 (2006) 235-241
31. Schapira A., Cooper J.M., Dexter D., Clark J.B., Jenner P., and Marsden C.D. Complex I deficiency in Parkinson's disease. J. Neurochem. 54 (1990) 823-827
32. Brown G. NO says yes to mitochondria. Science 299 (2003) 838-839
33. Moncada S., and Erusalimsky J.D. Does nitric oxide modulate mitochondrial energy generation and apoptosis?. Nat. Rev., Mol. Cell Biol. 3 (2002) 214-220
34. Chance B., Sies H., and Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol. Rev. 59 (1979) 527-605
35. Cohen G., and Kesler N. Monoamine oxidase inhibits mitochondrial respiration. Ann. N.Y. Acad. Sci. 893 (1999) 273-278
36. Solenski N.J., Kostecki V.K., Dovey S., and Periasamy A. Nitric-oxide-induced depolarization of neuronal mitochondria: implications for neuronal cell death. Mol. Cell. Neurosci. 24 (2003) 1151-1169
37. Figueroa S., Oset-Gasque M.J., Arce C., Martinez-Honduvilla C.J., and Gonzalez M.P. Mitochondrial involvement in nitric oxide-induced cellular death in cortical neurons in culture. J. Neurosci. Res. 83 (2006) 441-449